Search results
Research explains new method to engineer immune cells that could treat multiple cancer patients
Medical Xpress· 5 days agoTo tackle these limitations, UCLA researchers have developed a new, clinically guided method to engineer more powerful immune cells called invariant natural killer T cells, or iNKT cells, that ...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 6 days agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
What Is Immunophenotyping?
Healthline· 6 days agoImmunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
FOX 59 Indianapolis· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 1 day agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
Report Highlights Big Gaps in Cancer Outcomes Based on Race
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoU.S. cancer death rates are continuing to drop, falling by 33% between 1991 and 2020. Black people...
Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by National Bank of Canada FI
ETF DAILY NEWS· 1 day agoNational Bank of Canada FI reduced its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 41.7% during the 4th quarter, according to its most recent 13F filing with ...
7 cancer disparities to watch for in 2024
Becker’s Hospital Review· 5 days agoIn 2024, more than 2 million new cancer cases are projected to be diagnosed, and more than 611,700 deaths from cancer are expected, a May American Association of Cancer Research report found ...
Arcellx (NASDAQ:ACLX) Upgraded by Evercore ISI to Strong-Buy
ETF DAILY NEWS· 5 days agoEvercore ISI upgraded shares of Arcellx (NASDAQ:ACLX – Free Report) to a strong-buy rating in a research note published on Monday morning, Zacks.com reports. Robert W. Baird boosted their price ...
Higher rates of cancer in minoritized communities | Newswise
Newswise· 6 days agoDespite the overall death rate from cancer in the U.S. falling by 33% between 1991 and 2020, many segments of the U.S. population experience a disproportionate cancer burden, according to the ...
